10-K Decoder · All companies

C4 Therapeutics, Inc.

CCCC · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$36.0M$35.6M+1.0%
Operating income−$115M−$120M+3.7%
Net income−$105M−$105M+0.3%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$8.50M$11.2M−24.1%
Operating income−$24.6M−$34.4M+28.5%
Net income−$21.8M−$32.2M+32.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was C4 Therapeutics's revenue in FY2025?
$36.0M in FY2025 (Fiscal year ended Dec 31, 2025), +1.0% vs $35.6M a year earlier, per its 10-K filed Feb 2026.
Was C4 Therapeutics profitable in FY2025?
No: net income was −$105M and operating income −$115M in FY2025.
What was C4 Therapeutics's revenue in Q3 2026?
$8.50M (−24.1% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.